How Healthcare Workers Can Manage Their Mental Health Amidst COVID-19
When we talk about populations who are vulnerable to getting COVID-19, the healthcare community always tops out the list. Doctors, nurses, and other healthcare...
University of Glasgow leads COVID-19 research response in Scotland
The MRC-University of Glasgow Centre for Virus Research (CVR) is at the heart of COVID-19 research response in Scotland and the UK.
Covid-19 is a...
Researchers highlight the impact of COVID 19 pandemic on patients with cancer
New collaborative research from Queen’s University Belfast, the University of Split, Croatia and King’s College London has shown that the response to the outbreak...
Queen’s University leading clinical trial on cell therapy treatment for COVID19 patients
Researchers at Queen’s University Belfast are leading a UK-wide clinical trial, offering an innovative cell therapy treatment for COVID-19 patients with acute respiratory failure.
This...
Oxford University Imaging Lab and Zegami comes together to target Cardiovascular disease
Zegami, the data visualisation company, has been appointed by Oxford University researchers at the Oxford Cardiovascular Clinical Research Facility to accelerate research into cardiovascular...
What Drugs Do with a Brain?
The brain is a complex body organ. It comprises a three-pound white and gray matter mass that is at the center of human activity....
Mount Sinai Discovers New Drug Combo to Induce High Rates of Human Beta Cell...
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a novel combination of two classes of drugs that, together, cause the...
Much shorter radiation treatment found to be safe, effective for people with soft tissue...
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center found that treating soft tissue sarcoma with radiation over a significantly...
Investigational Subcutaneous Formulation of Vedolizumab Achieves Clinical Remission at Week 52 in Patients with...
Takeda Pharmaceutical Company Limited announced results from the phase 3 VISIBLE 2 clinical trial evaluating the efficacy and safety of an investigational subcutaneous (SC)...
Imminence of New Gonorrhea Therapeutic Drugs is Evident as the Bacteria Grow Super Resistant...
According to a new study, the gonorrhea therapeutics market will reach US$ 970 Mn in 2019, and estimated to register a 4% Y-o-Y over...
